Stéphanie Fry

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 168 citations · Full text

Asthma, Severe Eosinophilic Asthma, Allergy +10

Effectiveness and safety of dupilumab for the treatment of severe asthma in a real‐life French multi‐centre adult cohort

Clairelyne Dupin, Drifa Belhadi, Laurent Guilleminault et al. · Clinical & Experimental Allergy · 2020 · 130 citations

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

David J. Jackson, Liam G. Heaney, Marc Humbert et al. · The Lancet · 2023 · 116 citations · Full text

The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study

Abdellatif Tazi, Constance de Margerie‐Mellon, Jean Marc Naccache et al. · Orphanet Journal of Rare Diseases · 2015 · 114 citations · Full text

Development of and Field Test Results for the CAHPS PCMH Survey

Sarah Hudson Scholle, Oanh Vuong, Lin Ding et al. · Medical Care · 2012 · 96 citations · Full text

Family Medicine, Engineering, Field Test Results +16